2004

John Welch, some-time contributor to The Trademark Blog and full-time expert on the Trademark Trial and Appeal Board, has started the TTABlog.

CNN.COM reports that the FDA has requested that Pfizer pull ads for VIAGRA, on the grounds that the lines such as “Remember the guy who used to be called ‘wild thing’?  Well, he’s back” make the unsubstantiated claim that VIAGRA restores previous levels of sexual desire (as opposed to the substantiated claim that it treats

New York Times: The FDA is expected today to approve the use of radio-frequeny identification devices (RFIDs) to help fight counterfeits in the prescription drug pipeline. At the cost of 20 to 50 cents per unit, the devices will probably not yet appear on individual unit packaging yet, but that will likely change as

OK, explain this to me.  I see the large patent firms disappearing one by one.  As far as I can tell, the Pennies, Fishes, Kenyons and Darbys of the world have been competently handling the largest, most complex patent litigations, since forever.  So when they merge into a larger firm it is not as if

Matthew Homann’s The (Non) Billable Hour askd me to contribute 5 important isues and developments in trademark law, to his 5 X 5 feature.  Four other IP practitioners chipped in with where they see patent and trademark law headed.  In short, I saw more use of ADR, more use of XML, and more Initial Interest